Valuation Amgen Inc. Toronto S.E.

Stocks

Market Closed - Toronto S.E. 23:24:12 23/10/2026 +04			5-day change	1st Jan Change
32.45 ^CAD	-1.96%		+1.72%	+30.64%

10-23	Amgen's Growth Drivers, Pipeline Could Support Longer-Term Outlook, Oppenheimer Says	MT
10-23	Oppenheimer Adjusts Amgen Price Target to $480 From $450, Maintains Outperform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	237,478	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	34.74%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	278,835	272,782	267,910
Change	-	11.7%	22.4%	-9.42%	17.8%	25.76%	-2.17%	-1.79%
P/E	21.9x	21.7x	23.1x	34.5x	23x	27.9x	24.9x	23.8x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	21.2x	17.2x	13.9x
PEG	-	1.2x	7.36x	-0.9x	0.3x	2.6x	2.1x	5.2x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	6.09x	5.88x	5.67x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	7.16x	6.76x	6.4x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	12.8x	12.3x	12.1x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	16.4x	15.4x	14.5x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	24.3x	18.2x	16.9x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	4.12%	5.51%	5.91%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.3%	2.43%	2.53%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.76	17.66	18.47
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	64%	60.3%	60.2%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	38,970	40,377	41,856
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,765	22,232	22,226
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,952	17,767	18,527
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,555	9,430	10,015
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,357	35,304	30,432
Reference price ²	224.97	262.64	288.02	260.64	327.31	439.26	439.26	439.26
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	540,632	-	-
Announcement Date	07/02/22	31/01/23	06/02/24	04/02/25	03/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.5x	18.29x	2.02%	636B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.67x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.46x	7.04x	18.70x	2.12%	444.93B
Weighted average by Cap.	35.14x	8.29x	20.39x	1.8%